Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
November 7, 1986

HTLV-III/LAV and the Monocyte/Macrophage

Author Affiliations

National Institutes of Health Bethesda, Md; University of Rochester Rochester, NY

JAMA. 1986;256(17):2390-2391. doi:10.1001/jama.1986.03380170106030

Three important articles1-3 in this issue of THE JOURNAL focus our attention on infection of monocytes by human T-cell lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV), the virus that causes acquired immunodeficiency syndrome. These articles show that a cell with the characteristics of a monocyte/macrophage is the predominantly infected cell in the brain and lung. They provide strong support for the concept that direct viral infection of these organs by HTLV-III/LAV causes central nervous system disease and lymphocytic interstitial pneumonia.

Although often overshadowed by devastating immunologic deficiency disease, a high incidence of neurological diseases, characteristically dementia with subacute encephalopathy, has been seen in HTLV-III-infected patients. In the majority of these patients, the neurological diseases were not associated with opportunistic pathogens, suggesting that the neurological disease was caused by the HTLV-III/LAV itself. Convincing evidence of the presence of the virus in the brain was first provided by Southern blot hybridization and